Mitochondria based therapeutics (MBTs) are the rage these days. Many scientists/companies are doing research in this arena. That's why I wasn't in a hurry to do the research for a couple more weeks. I don't feel in a hurry since I thought the price was too high for where they are now. Apparently, others feel differently. It would have been a great flip from the day I created this board.
We are looking at this very early since there hasn't been a ph1 safety trial yet on any of their drug candidates. Was a trial start date mentioned in the call? Has an IND been submitted to the FDA?
It will be interesting to follow their progress. All of these companies targeting anti-aging and healthspan are of great interest to me. It seems that diabetes and alzheimer's are common targets for them.